speaker-icon

Latest Posts

anavex_partex_partnership_Innoplexus

27

Jun 23

Strategic partnership announcement: Innoplexus holding company Partex NV is pleased to announce a one-of-its-kind collaboration with Anavex Life science corp. for Artificial Intelligence (AI) enabled drug development and healthcare sales marketing

Exciting News! Anavex Life Sciences and Partex NV Announce Strategic Partnership to Enhance Patient Experience. Anavex Life Sciences Corp. and Partex NV N.V. Group are pleased to...
Read More
Kittu-Press-Release

9

Feb 23

AI supports targeted therapy recommendations fortumor diseases – BMBF funds joint research projectat University Medical Center Mainz with 2.53 millionEuros

The treatment and support of patients with advanced tumor diseases is a complex task involving numerous disciplines. For the interdisciplinary...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More

Archives: News

bio-it-world

Innoplexus at Bio-IT World

Excited to announce that Innoplexus is a gold sponsor of Bio-IT World Conference & Expo which is a 3 day event being held from 23rd May to 25th May 2017 at the Seaport World Trade Center in Boston, United States Of America. This event will feature various sectors from the Bioinformatics industry. Our Founder and …

Innoplexus at Bio-IT World Read More »

innoplexus-featured-dataquest

Innoplexus Featured in DataQuest

Innoplexus launches iPlexus to transform decision support in the Life Sciences Industry Innoplexus, the technology and product development company focused on AI and advanced analytics, announced the launch of its product iPlexus, an end to end platform for Life Sciences which leverages artificial intelligence to generate continuous intelligence and insights across discovery, clinical development, regulatory …

Innoplexus Featured in DataQuest Read More »

innoplexus-sign

Innoplexus signs MoU to provide academic license for its iPlexus platform to Regional Cancer Centre, Gwalior, India

Innoplexus is proud to announce our collaboration with the Regional Cancer Centre, Gwalior. Innoplexus has executed an MoU to provide an academic license for its iPlexus platform to RCC, Gwalior, India. The academic license allows doctors and researchers with free access to iPlexus. Doctors and researchers will be able to gain insights into the latest …

Innoplexus signs MoU to provide academic license for its iPlexus platform to Regional Cancer Centre, Gwalior, India Read More »

German VC firm invests in Data as a Service startup Innoplexus

German VC firm invests in Data as a Service startup Innoplexus

Innoplexus, a Germany- and India-based Data as a Service (DaaS) startup, has closed an undisclosed sum in pre-Series A funding from HCS, a Germany-based Venture VC firm. With the capital, the startup plans to file more patent applications, further develop its trademark platform iPlexus, and invest in marketing.